Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.


Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019

From Critical Care Explorations

The authors sought to determinewhether placental cell therapy PLacental eXpanded (PLX)-PAD (Pluristem Therapeutics, Haifa, Israel) was beneficial to treating critically ill patients suffering from acute respiratory distress syndrome due to coronavirus disease 2019.

Authors:

Barkama R, Mayo A, Paz A, et al. 


Estimated Time: 24:18

Categories: Hematology, Disaster,
Content Type: Articles,